CLINICAL_TRIALS
trial_result
· 2016-05-18
Clinical Trial Update: Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease [Phase 4]
Summary
A Phase 4 clinical trial investigates the effect of melatonin on sleep disturbances in Parkinson's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kuhnil Pharmaceutical Co., Ltd. | Conditions: Parkinson's Disease | Phase 4 | Status: UNKNOWN